YourHealthRx review

What it is

YourHealthRx is a peptide and longevity telehealth platform that routes intake into partner clinical workflows rather than prescribing itself. Its compound pages are organised by molecule and format: sermorelin as an injectable or an oral troche, NAD⁺ as a nasal spray or as injectable vials in 5 mL and 10 mL, glutathione as an injectable or a troche. Its wider educational catalog covers CJC-1295/ipamorelin, tesamorelin, BPC-157, TB-500, GHK-Cu, KPV and PT-141 alongside compounded semaglutide and tirzepatide, plus lab tests, protocols and an eligibility quiz. It positions itself as "the middle path" between gray-market research chemicals and conventional care.

How it works

A four-step referral pipeline, described more precisely than most: intake screening covering current medications, history, goals and symptoms; review by a licensed clinician from a partner network; prescription issuance where appropriate; and dispensing by a compliant pharmacy. The clinician network is stated to hold active licences across all US states, either individually or through the Interstate Medical Licensure Compact, and the site correctly explains why that matters — a telehealth prescriber must hold a licence in the patient's state of residence. What distinguishes this platform is how much it disclaims. Its own pages repeat that YourHealthRx does not diagnose, treat, prescribe, review labs or determine dosing; that listing an option is not a guarantee it is appropriate, available in your state, or that any prescription will be issued; and that eligibility, titration and follow-up all rest with the prescribing clinician. It also draws a line most sites blur, noting that telemedicine consultations reach all 50 states while pharmacy fulfilment does not, with state and product-specific exclusions. The cost of that candour is accountability diffusion: when the platform you buy from is explicitly not the prescriber and explicitly not the pharmacy, and neither the partner clinical workflow nor the dispensing pharmacy is named, there is no one identifiable standing behind the vial. No individual clinician, medical director or LegitScript certification is published either.

Pricing transparency

There is none to assess, and that is the finding. Every compound page — sermorelin, NAD⁺, glutathione alike — carries the same closing line: compounded medications are not FDA-approved, a prescription is required and is not guaranteed, and "Pricing is determined following clinician review based on your individualized protocol." No figure appears against any molecule on any of them. That is a change from the record we hold, which captured a priced GLP-1 line, and it means a reader cannot compare this platform against anything on either of our boards without completing an intake first. We publish no floor on either board as a result. Two consequences worth naming. First, an individualised-protocol model makes price a moving target by design, so ask for the first charge, the recurring charge and the billing cadence in writing before you hand over health history. Second, because the platform states it is not the pharmacy, confirm whether the price you are eventually quoted is a platform fee, a medication cost, or both. Nothing on the site indicates a membership, and nothing indicates there isn't one.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed clinician finds it appropriate. The disclosure is repeated on every compound page rather than buried in a footer, which is good practice, and the site states that prescribing runs through partner clinical workflows staffed by physicians, nurse practitioners and physician assistants. No pharmacy is named, and compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, its catalog spans the full range and the site's own framing — "discussed for" a goal rather than "treats" it — is more careful than most. Sermorelin, CJC-1295/ipamorelin and tesamorelin act on the growth-hormone axis; tesamorelin is an approved drug for HIV-associated lipodystrophy specifically, and the others have real mechanisms with thin long-term human outcome data. Injected and intranasal NAD⁺ have no controlled human outcome trials; the oral precursors NR and NMN are the studied forms and what they demonstrate is a raised blood level. Glutathione, GHK-Cu, BPC-157, TB-500 and KPV have essentially no controlled human outcome data. PT-141 is an approved drug for one narrow indication — generalised hypoactive sexual desire disorder in premenopausal women — so prescribing it to anyone else is off-label use of an approved molecule. Individual results vary.

Pros and watch-outs

The evidence behind what YourHealthRx prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• Ipamorelin & CJC-1295: the honest evidence on GH secretagogue peptides

  They reliably raise growth hormone — that part is real. The muscle, fat-loss and anti-aging claims are not supported by human outcome data. A straight read.

• Tesamorelin (Egrifta): what it's actually FDA-approved for, and the evidence

  A real, approved GHRH analog — for HIV-associated lipodystrophy specifically. What the pivotal trials showed, and why the longevity use is an extrapolation.

• BPC 157: what the evidence actually shows (and what it doesn't)

  The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.

• TB-500 and thymosin beta-4: separating the trials from the hype

  Real Phase 2 dry-eye data, deep preclinical neuro/cardiac work, and a recovery-market use that was never actually tested.

• GHK-Cu: the copper peptide between real skincare and overclaim

  A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.

• KPV peptide: what the evidence actually shows (benefits, dosage talk, and side effects)

  KPV is the anti-inflammatory tripeptide tail of α-MSH, sold for gut, inflammation, wound-healing and skin. The mechanism is real and the mouse data are real — but there are essentially no human trials. A straight read of where the science stands.

• PT-141 (bremelanotide): the evidence on a research-popular peptide that is actually FDA-approved

  Bremelanotide (Vyleesi) is FDA-approved for HSDD in premenopausal women, with phase-3 trial evidence. A straight read of what's proven — and where off-label use goes beyond it.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• NAD injections: how to get them near you or online, and what the evidence really says

  Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.

• NAD⁺ nasal spray: the delivery format with the least direct evidence

  Intranasal NAD⁺ is convenient and heavily marketed — but no controlled human trial shows the spray raises systemic or brain NAD⁺. A straight comparison with the better-studied routes.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

How YourHealthRx compares

A few alternatives worth a look, depending on what you’re optimizing for.

• YHYOURx Health

  People choosing between an NAD⁺ injection and a nasal spray on published prices

  See YOURx Health →
• WWWhoosh Wellness

  NAD⁺ buyers who want the injection and the nasal spray priced identically and all-in

  See Whoosh Wellness →
• PEPeptidesRx

  NAD⁺ buyers who want milligrams and concentration stated, not just a monthly fee

  See PeptidesRx →